Lynette C. Daws

6.4k total citations
106 papers, 4.1k citations indexed

About

Lynette C. Daws is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Lynette C. Daws has authored 106 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Cellular and Molecular Neuroscience, 53 papers in Molecular Biology and 12 papers in Endocrine and Autonomic Systems. Recurrent topics in Lynette C. Daws's work include Neurotransmitter Receptor Influence on Behavior (77 papers), Neuroscience and Neuropharmacology Research (51 papers) and Receptor Mechanisms and Signaling (45 papers). Lynette C. Daws is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (77 papers), Neuroscience and Neuropharmacology Research (51 papers) and Receptor Mechanisms and Signaling (45 papers). Lynette C. Daws collaborates with scholars based in United States, France and Australia. Lynette C. Daws's co-authors include William A. Owens, Georgianna G. Gould, Aurelio Galli, Wouter Koek, Alan Frazer, Randy Blakely, Greg A. Gerhardt, Rebecca E. Horton, Glenn M. Toney and Sylvia Montañez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Lynette C. Daws

103 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynette C. Daws United States	36	2.4k	1.6k	586	506	485	106	4.1k
Colin N. Haile United States	35	2.1k 0.9×	1.3k 0.8×	581 1.0×	517 1.0×	406 0.8×	86	4.0k
Declan N.C. Jones United Kingdom	37	1.7k 0.7×	1.2k 0.8×	683 1.2×	637 1.3×	657 1.4×	64	3.4k
Kurt Rasmussen United States	36	2.5k 1.1×	1.6k 1.0×	856 1.5×	479 0.9×	517 1.1×	75	4.3k
Sharon Rosenzweig‐Lipson United States	34	1.8k 0.7×	1.2k 0.7×	409 0.7×	405 0.8×	503 1.0×	72	3.4k
Lalit K. Srivastava Canada	35	2.1k 0.9×	1.6k 1.0×	746 1.3×	492 1.0×	547 1.1×	94	4.2k
Heath D. Schmidt United States	40	3.0k 1.2×	1.9k 1.2×	763 1.3×	680 1.3×	680 1.4×	86	5.5k
Gregg D. Stanwood United States	39	2.0k 0.8×	1.7k 1.1×	617 1.1×	219 0.4×	275 0.6×	80	4.6k
Vidita A. Vaidya India	38	2.2k 0.9×	1.2k 0.8×	596 1.0×	620 1.2×	1.0k 2.1×	91	4.8k
Michelle S. Mazei‐Robison United States	32	1.8k 0.8×	1.1k 0.7×	598 1.0×	480 0.9×	749 1.5×	51	3.3k
Stephen J. Gold United States	26	2.3k 1.0×	2.0k 1.3×	524 0.9×	738 1.5×	986 2.0×	34	4.9k

Countries citing papers authored by Lynette C. Daws

Since Specialization

Citations

This map shows the geographic impact of Lynette C. Daws's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynette C. Daws with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynette C. Daws more than expected).

Fields of papers citing papers by Lynette C. Daws

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynette C. Daws. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynette C. Daws. The network helps show where Lynette C. Daws may publish in the future.

Co-authorship network of co-authors of Lynette C. Daws

This figure shows the co-authorship network connecting the top 25 collaborators of Lynette C. Daws. A scholar is included among the top collaborators of Lynette C. Daws based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynette C. Daws. Lynette C. Daws is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mayer, Felix P., Adele Stewart, Amy E. Moritz, et al.. (2025). Kappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant. Molecular Psychiatry. 30(10). 4651–4664. 1 indexed citations

Desai, M., et al.. (2024). Effects of access condition on substance use disorder-like phenotypes in male and female rats self-administering MDPV or cocaine. Drug and Alcohol Dependence. 263. 112408–112408.

Mayer, Felix P., William A. Owens, Marjorie A. Bowman, et al.. (2023). Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuse. Molecular Psychiatry. 28(7). 2934–2945. 9 indexed citations

Daws, Lynette C., et al.. (2023). Organic cation transporters in psychiatric and substance use disorders. Pharmacology & Therapeutics. 253. 108574–108574. 5 indexed citations

Gómez, Jorge A., et al.. (2022). Faster Serotonin Clearance in CA3 Region of Hippocampus and Antidepressant-like Effect of Decynium-22 in Juvenile Mice Are Putatively Linked to Increased Plasma Membrane Monoamine Transporter Function: Implications for Efficacy of Antidepressants in Juveniles. Cells. 11(15). 2454–2454. 2 indexed citations

Koek, Wouter, et al.. (2021). Role of Organic Cation Transporter 3 and Plasma Membrane Monoamine Transporter in the Rewarding Properties and Locomotor Sensitizing Effects of Amphetamine in Male andFemale Mice. International Journal of Molecular Sciences. 22(24). 13420–13420. 9 indexed citations

Koek, Wouter, et al.. (2020). Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice. International Journal of Molecular Sciences. 21(20). 7581–7581. 21 indexed citations

Jensen, Mathias E., Aurelio Galli, Morgane Thomsen, et al.. (2020). Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent. Neurochemistry International. 138. 104772–104772. 27 indexed citations

Gilman, T. Lee, William A. Owens, Lívia Garcia Ferreira, et al.. (2019). Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm. Journal of Pharmacology and Experimental Therapeutics. 371(2). 268–277. 9 indexed citations

10.

Dencker, Ditte, William A. Owens, Nikolaj Riis Christensen, et al.. (2018). PICK1-Deficient Mice Exhibit Impaired Response to Cocaine and Dysregulated Dopamine Homeostasis. eNeuro. 5(3). ENEURO.0422–17.2018. 13 indexed citations

11.

Mayer, Felix P., Diethart Schmid, Marion Holy, Lynette C. Daws, & Harald H. Sitte. (2018). “Polytox” synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux. Neurochemistry International. 123. 7–12. 10 indexed citations

12.

Krause‐Heuer, Anwen M., Naomi A. Wyatt, Georgianna G. Gould, et al.. (2017). Evaluation of the antidepressant therapeutic potential of isocyanine and pseudoisocyanine analogues of the organic cation decynium-22. European Journal of Medicinal Chemistry. 137. 476–487. 9 indexed citations

13.

Daws, Lynette C., et al.. (2013). Revisiting Serotonin Reuptake Inhibitors and the Therapeutic Potential of “Uptake-2” in Psychiatric Disorders. ACS Chemical Neuroscience. 4(1). 16–21. 41 indexed citations

14.

Hensler, Julie G., Francesc Artigas, Analı́a Bortolozzi, et al.. (2013). Catecholamine/Serotonin Interactions. Advances in pharmacology. 68. 167–197. 58 indexed citations

15.

Lamb, R. J., Jonathan W. Pinkston, & Lynette C. Daws. (2013). Ethanol effects on multiple fixed-interval, fixed-ratio responding in mice with deletions of the serotonin transporter gene. Behavioural Pharmacology. 25(1). 92–95. 1 indexed citations

16.

Veenstra‐VanderWeele, Jeremy, Christopher L. Muller, Hideki Iwamoto, et al.. (2012). Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proceedings of the National Academy of Sciences. 109(14). 5469–5474. 246 indexed citations

17.

Owens, William A., Jason M. Williams, Christine Saunders, et al.. (2012). Rescue of Dopamine Transporter Function in Hypoinsulinemic Rats by a D₂Receptor–ERK-Dependent Mechanism. Journal of Neuroscience. 32(8). 2637–2647. 34 indexed citations

18.

Owens, William A., Rajkumar J. Sevak, Ruggero Galici, et al.. (2005). Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. Journal of Neurochemistry. 94(5). 1402–1410. 68 indexed citations

19.

Callaghan, Paul D., Rodney J. Irvine, & Lynette C. Daws. (2005). Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochemistry International. 47(5). 350–361. 30 indexed citations

20.

Montañez, Sylvia, William A. Owens, Georgianna G. Gould, Dennis L. Murphy, & Lynette C. Daws. (2003). Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. Journal of Neurochemistry. 86(1). 210–219. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact